Learn from experts in the field on key issues for safe neuromuscular blockade and reversal strategies. Topics include discussion of the current process of neuromuscular blockade (NMB) monitoring and reversal with a focus on the anesthesiologist perspective in the operating room. Cost considerations when monitoring and reversing NMB will also be discussed.
SPEAKERS
J. Ross Renew, MD, FASA, FASE, is currently an Assistant Professor of Anesthesiology and serves as the Vice Chair of Research for his department at the Mayo Clinic in Jacksonville, Florida. Dr. Renew completed his anesthesiology residency at Mayo Clinic in Jacksonville, Florida and his Adult Cardiothoracic Anesthesiology at Mayo Clinic in Rochester, Minnesota.
Dr. Renew is an active researcher and leads a team interested in neuromuscular blockade, neuromuscular blockade monitoring, and practical strategies to optimize neuromuscular blockade management. In addition to his research efforts, he serves as the Associate Residency Director and is passionate about educating the next generation of anesthesiologists on the best way to manage neuromuscular blockade.
Rachel C. Wolfe, PharmD, MHA, BCCCP, is Clinical Pharmacy Specialist of Perioperative and Surgical Critical Care at Barnes-Jewish Hospital and Washington University Medical Center in St. Louis, Missouri. She is also Adjunct Clinical Instructor for the Barnes-Jewish Hospital Goldfarb School of Nursing and St. Louis College of Pharmacy. , Dr. Wolfe is responsible for the provision of clinical pharmacy services in the perioperative and periprocedural environment and for the coordination of clinical services provided by four operating room pharmacy satellites. She also serves as a preceptor for Doctor of Pharmacy students and pharmacy residents and is co-chair of the Enhanced Surgical Recovery Pharmacy & Documentation committee and the Analgesia subcommittee of the Pharmacy & Therapeutics committee.
Dr. Wolfe earned her Doctor of Pharmacy degree from St. Louis College of Pharmacy and Master of Health Administration degree from Webster University, also in St. Louis. She completed her residency training at University of Kentucky HealthCare, and she is board certified in critical care.
Dr. Wolfe is a member of the American College of Clinical Pharmacy, American Society of Enhanced Recovery, and Society of Critical Care Medicine. In 2011 she received Barnes-Jewish Hospital’s David A. Gee Meritorious Service Award and Team Award for Quality Improvement for Anesthesia Medication Management.
Relevant Financial Relationship Disclosures
The following persons in control of this activity’s content have relevant financial relationships:
Rachel C. Wolfe - Merck: advisor and speaker's bureau
J. Ross Renew - Merck: investigator for a research grant
All other persons in control of content do not have any relevant financial relationships with an ineligible company.
As defined by the Standards of Integrity and Independence in Accredited Education definition of ineligible company. All relevant financial relationships have been mitigated prior to the activity.
Provided by ASHP
Supported by an educational grant from Merck